1
3
4
News & Events
Foghorn Therapeutics Highlights Recent Clinical and Research Progress
January 9, 2023
Also announced strategic objectives for 2023. Read more
InterVenn Biosciences Enters Next Stage with Senior Management Team Updates
January 5, 2023
The company announced changes to its senior management team to support its commercialization execution. Read more
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
December 6, 2022
Acutus' flagship product now certified under the new European Medical Device Regulations. Read more
6
7
News & Events
Foghorn Therapeutics Highlights Recent Clinical and Research Progress
January 9, 2023
Also announced strategic objectives for 2023. Read more
InterVenn Biosciences Enters Next Stage with Senior Management Team Updates
January 5, 2023
The company announced changes to its senior management team to support its commercialization execution. Read more
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
December 6, 2022
Acutus' flagship product now certified under the new European Medical Device Regulations. Read more
14
Championing
collaborations
that improve health
and the quality of life
for everyone.

#JoinForces
#LifeSciencesInTheFuture
21
25
29
35
37
News & Events
Foghorn Therapeutics Highlights Recent Clinical and Research Progress
January 9, 2023
Also announced strategic objectives for 2023. Read more
InterVenn Biosciences Enters Next Stage with Senior Management Team Updates
January 5, 2023
The company announced changes to its senior management team to support its commercialization execution. Read more
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
December 6, 2022
Acutus' flagship product now certified under the new European Medical Device Regulations. Read more
39
41